Researchers in a recent study discovered that people taking medications to help them lose weight might experience weight gain ...

Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid ...

People may start to regain weight within weeks of discontinuing weight loss drugs, study finds - Study finds significant ...

Some health experts view GLP-1s as a promising option for PCOS, which lacks a standard treatment and affects millions of ...

A promising experimental drug is one more sign of the impending disruption the booming Chinese biotech industry could bring ...

A new study finds four factors that may make it more likely for some people to experience successful weight loss from using GLP-1Rs such as Ozempic or Wegovy.

The saga began early last year when Regeneron filed a lawsuit accusing Amgen of infringing a key patent on its best-selling Eylea injectable drug, which is used to combat such eye diseases as wet ...

Several companies have been sanctioned for unlawfully advertising prescription-only weight-loss drugs directly to the UK public.

New Monthly GLP-1 Could Be as Good as Ozempic, Mounjaro for Weight Loss MariTide, a new drug from Amgen, helped some people with obesity lose up to 20% of their body weight.

CHICAGO — Dapiglutide, a novel GLP-1/GLP-2 receptor agonist, was associated with body weight reductions of up to 8.3% at 13 weeks for patients with overweight or obesity in an early study ...